sulfinpyrazone has been researched along with Embolus in 3 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Weiss, M | 1 |
Barnett, HJ | 1 |
Verstraete, M | 1 |
2 reviews available for sulfinpyrazone and Embolus
Article | Year |
---|---|
The pathophysiology of transient cerebral ischemic attacks.
Topics: Arteriosclerosis; Aspirin; Carotid Arteries; Cerebrovascular Disorders; Cholesterol; Embolism; Endoc | 1979 |
[Prophylactic value of platelet anti-aggregants in coronary disease].
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Embolism; Hea | 1979 |
1 other study available for sulfinpyrazone and Embolus
Article | Year |
---|---|
Potentiation of coumarin effect by sulfinpyrazone.
Topics: Coumarins; Drug Synergism; Drug Therapy, Combination; Embolism; Humans; Middle Aged; Postoperative C | 1979 |